Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2022 | 03-2021 | 03-2020 | 03-2019 | 03-2018 | |
| Sales | 230,972 | 59,317 | 0 | 0 | 0 |
| Cost of Goods | 11,510 | 301 | N/A | N/A | N/A |
| Gross Profit | 219,462 | 59,016 | N/A | N/A | N/A |
| Operating Expenses | 407,318 | 320,101 | 274,887 | 264,826 | 141,063 |
| Operating Income | -187,346 | -260,784 | -274,887 | -264,826 | -141,063 |
| Interest Expense | 13,971 | 10,401 | 12,663 | 8,821 | 2,046 |
| Other Income | 384 | 16,387 | -678 | 572 | 67 |
| Pre-tax Income | -200,933 | -254,798 | -288,228 | -273,075 | -143,042 |
| Income Tax | 5,048 | 336 | 761 | 476 | 213 |
| Net Income Continuous | -205,981 | -255,134 | -288,989 | -273,551 | -143,255 |
| Net Income | $-205,981 | $-255,134 | $-288,989 | $-273,551 | $-143,255 |
| EPS Basic Total Ops | -2.22 | -2.83 | -3.37 | -4.09 | -2.41 |
| EPS Basic Continuous Ops | -2.22 | -2.83 | -3.37 | -4.09 | -2.41 |
| EPS Diluted Total Ops | -2.22 | -2.83 | -3.37 | -4.09 | -2.41 |
| EPS Diluted Continuous Ops | -2.22 | -2.83 | -3.37 | -4.09 | -2.41 |
| EPS Diluted Before Non-Recurring Items | -2.22 | -2.83 | -3.37 | -4.09 | -2.41 |
| EBITDA(a) | $-181,861 | $-257,670 | $-271,636 | $-262,304 | $-140,158 |